1.33 USD
+0.01 (+0.76%)
1.33 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 82% to OPK. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.74. This target is 181.46% above the current price.
OPK was analyzed by 10 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about OPK.
In the previous month the buy percentage consensus was at a similar level.
OPK was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-20 | JP Morgan | Initiate | Neutral |
| 2025-10-31 | Jefferies | Downgrade | Buy -> Hold |
| 2025-10-30 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-05-01 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-04-25 | JP Morgan | Initiate | Neutral |
| 2025-04-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-12 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-03-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-28 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-01-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-20 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-17 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-09-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-07-18 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-05-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-01 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-04-01 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-02-28 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-02-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-29 | Barrington Research | Upgrade | Market Perform -> Outperform |
| 2023-05-05 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-09 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-24 | HC Wainwright & Co. | Reiterate | Buy |
OPKO HEALTH INC / OPK FAQ
Can you provide the average price target for OPKO HEALTH INC stock?
10 analysts have analysed OPK and the average price target is 3.74 USD. This implies a price increase of 181.46% is expected in the next year compared to the current price of 1.33.
How do analysts rate OPKO HEALTH INC (OPK)?
The consensus rating for OPKO HEALTH INC (OPK) is 82 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for OPK stock?
The number of analysts covering OPKO HEALTH INC (OPK) is 10.